ADAP(Delisted)
AdaptimmuneยทNASDAQ
--
--(--)
Is ADAP fundamentally strong?
- ADAP scores 0.00/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -260.82% net margin, 0.00 P/E ratio, 0.00 P/B ratio, and -83.33% earnings growth, these metrics solidify its Neutral investment rating.
